OLMA
Olema Pharmaceuticals, Inc.
+0.37 (+3.80%)10.10USD277K成交股數884M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 57.8M | 49.2M | 40.0M | 43.9M | 30.6M | 32.3M | 33.2M | 29.1M | 29.9M | 19.5M | 18.0M | 22.8M |
| 銷售管理費用 | 9.4M | 8.8M | 5.9M | 4.0M | 4.2M | 4.5M | 4.4M | 4.4M | 4.5M | 3.9M | 3.6M | 6.8M |
| 營業利益 | −67.2M+93% | −58.0M+58% | −45.9M+22% | −47.9M+43% | −34.9M+2% | −36.8M+58% | −37.6M+74% | −33.5M+13% | −34.3M | −23.3M | −21.6M | −29.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −63.2M+108% | −53.1M+58% | −42.2M+22% | −43.8M+44% | −30.4M-2% | −33.6M+56% | −34.6M+72% | −30.4M+7% | −31.0M | −21.5M | −20.1M | −28.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.61+69% | -0.52+4% | -0.49-18% | -0.51-6% | -0.36-36% | -0.50+4% | -0.60+22% | -0.54-23% | -0.56 | -0.48 | -0.49 | -0.70 |
| 稀釋股數 | 104M | 103M | 85.7M | 85.5M | 85.4M | 58.7M | 57.3M | 56.3M | 55.6M | 45.0M | 40.7M | 40.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 48.6M | 52.5M | 35.3M | 52.5M | 50.6M | 139M | 35.9M | 16.9M | 33.7M | 117M | 35.0M | 40.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 487M | 531M | 352M | 382M | 410M | 451M | 230M | 255M | 264M | 293M | 178M | 196M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 56.0M | 50.2M | 45.0M | 36.8M | 26.2M | 42.0M | 31.3M | 27.4M | 27.4M | 17.7M | 16.0M | 20.8M |
| 股東權益 | 431M | 480M | 307M | 345M | 383M | 409M | 199M | 227M | 236M | 275M | 162M | 175M |
| 負債比 | 11.5% | 9.5% | 12.8% | 9.6% | 6.4% | 9.3% | 13.6% | 10.8% | 10.4% | 6.0% | 9.0% | 10.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −46.0M | – | – | −44.0M+87% | – | – | – | −23.5M | – | – | −20.4M |
| 資本支出 | – | – | – | – | – | – | – | – | 153K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −23.6M | – | – | – |
| 折舊攤銷 | – | 119K | – | – | 128K | – | – | – | 88K | – | – | 100K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −162M | –% | -1.87 | – |
| FY2024 | – | – | −129M | –% | -2.20 | −105M |
| FY2023 | – | – | −96.7M | –% | -2.14 | – |
| FY2022 | – | – | −105M | –% | -2.62 | −82.4M |
| FY2021 | – | – | −71.1M | –% | -1.80 | −52.3M |
| FY2020 | – | – | −22.1M | –% | -3.42 | −19.9M |
| FY2019 | – | – | −4.3M | –% | -1.66 | – |